Shopping Cart 0
Cart Subtotal
USD 0

Sanofi SA - Strategy, SWOT and Corporate Finance Report

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 175

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 350

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 525
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase

Details

Sanofi SA-Strategy, SWOT and Corporate Finance Report

Summary

Sanofi SA-Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.

Key Highlights

Sanofi SA (Sanofi or 'the group') is a France-based international pharmaceutical group engaged in research, development, manufacture and marketing of healthcare products. The group offers a range of products related to rare diseases, multiple sclerosis, oncology, diabetes, and cardiovascular diseases. In addition, it provides prescription products, consumer healthcare products, generics, and vaccines. It offers products related to Vaccines that include pediatric vaccines for diphtheria, tetanus, pertussis, polio and haemophilus influenzae type b (Hib), influenza vaccines and adult and adolescent booster vaccines. The group operates across North America and Europe. Sanofi is headquartered in Paris, France.

Scope

- Detailed information on Sanofi SA required for business and competitor intelligence needs

- A study of the major internal and external factors affecting Sanofi SA in the form of a SWOT analysis

- An in-depth view of the business model of Sanofi SA including a breakdown and examination of key business segments

- Intelligence on Sanofi SA's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

- News about Sanofi SA, such as business expansion, restructuring, and contract wins

- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Sanofi SA and the factors that influence its strategies.

- Track strategic initiatives of the company and latest corporate news and actions.

- Assess Sanofi SA as a prospective partner, vendor or supplier.

- Support sales activities by understanding your customers' businesses better.

- Stay up to date on Sanofi SA's business structure, strategy and prospects.

READ MORE

Table Of Content

Scope

Table of Contents

Company Snapshot 2

Table of Contents 5

Sanofi SA: Company Overview 9

Sanofi SA: Overview and Key Facts 9

Sanofi SA: Overview 9

Sanofi SA: Key Facts 9

Sanofi SA: Key Employees 11

Sanofi SA: Key Employee Biographies 13

Sanofi SA: Major Products and Services 14

Sanofi SA: Company History 15

Sanofi SA: Management Statement 27

Sanofi SA: Locations and Subsidiaries 29

Sanofi SA: Key Competitors 30

Sanofi SA: Company Analysis 31

Sanofi SA: Business Description 31

Sanofi SA: SWOT Analysis 33

Sanofi SA: SWOT Overview 33

Sanofi SA: Strengths 33

Sanofi SA: Weaknesses 34

Sanofi SA: Opportunities 34

Sanofi SA: Threats 34

Sanofi SA: Corporate Financial Deals Activity 37

Sanofi SA: Financial Deals Overview 37

Sanofi SA: Targets and Partners 39

Sanofi SA: Top Deals 2014-2018YTD 42

Sanofi SA: Advisors 43

Sanofi SA: Top Legal Advisors 43

Sanofi SA: Top Financial Advisors 43

Sanofi SA: Mergers and Acquisitions 45

Sanofi SA: Corporate Venturing 46

Sanofi SA: Capital Raising 47

Sanofi SA: Partnership 48

Sanofi SA: Divestments 49

Sanofi SA: Recent Developments 50

Sanofi SA: News and Events Summary 50

Sanofi SA: Business Expansion 54

Sanofi SA: Contracts 55

Sanofi SA: Corporate Governance 56

Sanofi SA: Financial Deals 57

Sanofi SA: Regulatory and Legal Events 57

Sanofi SA: Strategy and Operations 58

Appendix 59

Contact Us 59

Methodology 59

About MarketLine 60


List Of Figure

List of Figures

Figure 1: Sanofi SA: Deal Activity by Deal Type-Volume (TTM )

Figure 2: Sanofi SA: M&A Activity by Geography (TTM )

Figure 3: Sanofi SA: Deal Activity by Deal Type-Volume (2014-YTD 2018)

Figure 4: Sanofi SA: M&A Average Deal Size-Value (USD m)

Figure 5: Sanofi SA: M&A Volume and Value Trend (2014-YTD 2018)

Figure 6: Sanofi SA: M&A Activity

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License: 
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:  
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com